REAL BROKERAGE INC/THE (REAX) Stock Fundamental Analysis
USA - NASDAQ:REAX - CA75585H2063 - Common Stock
3.57 USD
-0.29 (-7.51%)
3.7 USD
+0.13 (+3.64%)
Overall REAX gets a fundamental rating of 4 out of 10. We evaluated REAX against 64 industry peers in the Real Estate Management & Development industry. REAX has a great financial health rating, but its profitability evaluates not so good. REAX is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
REAX had negative earnings in the past year.
REAX had a positive operating cash flow in the past year.
In the past 5 years REAX always reported negative net income.
Of the past 5 years REAX 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -8.49%, REAX is doing worse than 67.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of -25.80%, REAX is doing worse than 67.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.49% | ||
| ROE | -25.8% | ||
| ROIC | N/A |
ROA(3y)-40.11%
ROA(5y)-33.2%
ROE(3y)-83.38%
ROE(5y)-70.74%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of REAX (8.90%) is worse than 67.19% of its industry peers.
REAX's Gross Margin has declined in the last couple of years.
REAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.9% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
2. Health
2.1 Basic Checks
REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REAX has more shares outstanding
The number of shares outstanding for REAX has been increased compared to 5 years ago.
There is no outstanding debt for REAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
REAX has an Altman-Z score of 14.61. This indicates that REAX is financially healthy and has little risk of bankruptcy at the moment.
REAX has a better Altman-Z score (14.61) than 90.63% of its industry peers.
There is no outstanding debt for REAX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 14.61 |
ROIC/WACCN/A
WACC8.63%
2.3 Liquidity
A Current Ratio of 1.29 indicates that REAX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.29, REAX perfoms like the industry average, outperforming 40.63% of the companies in the same industry.
A Quick Ratio of 1.29 indicates that REAX should not have too much problems paying its short term obligations.
REAX has a Quick ratio of 1.29. This is comparable to the rest of the industry: REAX outperforms 42.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
REAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.68%, which is quite impressive.
REAX shows a strong growth in Revenue. In the last year, the Revenue has grown by 72.57%.
REAX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 140.25% yearly.
EPS 1Y (TTM)73.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)72.57%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%58.68%
3.2 Future
The Earnings Per Share is expected to grow by 29.71% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 29.76% on average over the next years. This is a very strong growth
EPS Next Y67.21%
EPS Next 2Y40.78%
EPS Next 3Y29.71%
EPS Next 5YN/A
Revenue Next Year56.06%
Revenue Next 2Y36.33%
Revenue Next 3Y29.76%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
REAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for REAX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, REAX is valued cheaply inside the industry as 90.63% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.03 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
REAX's earnings are expected to grow with 29.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.78%
EPS Next 3Y29.71%
5. Dividend
5.1 Amount
REAX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.57
-0.29 (-7.51%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners37.27%
Inst Owner Change0.48%
Ins Owners11.55%
Ins Owner ChangeN/A
Market Cap747.20M
Revenue(TTM)1.62B
Net Income(TTM)-12688000
Analysts86
Price Target6.46 (80.95%)
Short Float %1.31%
Short Ratio1.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)174.29%
Min EPS beat(2)56.43%
Max EPS beat(2)292.16%
EPS beat(4)4
Avg EPS beat(4)112.64%
Min EPS beat(4)34.64%
Max EPS beat(4)292.16%
EPS beat(8)6
Avg EPS beat(8)44.38%
EPS beat(12)8
Avg EPS beat(12)29.56%
EPS beat(16)11
Avg EPS beat(16)26.23%
Revenue beat(2)2
Avg Revenue beat(2)7.06%
Min Revenue beat(2)4.24%
Max Revenue beat(2)9.88%
Revenue beat(4)4
Avg Revenue beat(4)8.49%
Min Revenue beat(4)4.24%
Max Revenue beat(4)14.54%
Revenue beat(8)8
Avg Revenue beat(8)13.04%
Revenue beat(12)12
Avg Revenue beat(12)14.82%
Revenue beat(16)16
Avg Revenue beat(16)21.29%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-500%
EPS NY rev (1m)0%
EPS NY rev (3m)-125%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.46 | ||
| P/FCF | 11.03 | ||
| P/OCF | 10.88 | ||
| P/B | 15.19 | ||
| P/tB | 19.63 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.05
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.32
FCFY9.06%
OCF(TTM)0.33
OCFY9.19%
SpS7.73
BVpS0.24
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.49% | ||
| ROE | -25.8% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.9% | ||
| FCFM | 4.19% |
ROA(3y)-40.11%
ROA(5y)-33.2%
ROE(3y)-83.38%
ROE(5y)-70.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
F-Score7
Asset Turnover10.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 65.54% | ||
| Cap/Sales | 0.06% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 14.61 |
F-Score7
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)185.96%
Cap/Depr(5y)132.21%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y67.21%
EPS Next 2Y40.78%
EPS Next 3Y29.71%
EPS Next 5YN/A
Revenue 1Y (TTM)72.57%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%58.68%
Revenue Next Year56.06%
Revenue Next 2Y36.33%
Revenue Next 3Y29.76%
Revenue Next 5YN/A
EBIT growth 1Y60.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.04%
EBIT Next 3Y81.38%
EBIT Next 5YN/A
FCF growth 1Y178.32%
FCF growth 3Y133%
FCF growth 5YN/A
OCF growth 1Y170.9%
OCF growth 3Y131.26%
OCF growth 5YN/A
REAL BROKERAGE INC/THE / REAX FAQ
What is the fundamental rating for REAX stock?
ChartMill assigns a fundamental rating of 4 / 10 to REAX.
What is the valuation status of REAL BROKERAGE INC/THE (REAX) stock?
ChartMill assigns a valuation rating of 2 / 10 to REAL BROKERAGE INC/THE (REAX). This can be considered as Overvalued.
What is the profitability of REAX stock?
REAL BROKERAGE INC/THE (REAX) has a profitability rating of 1 / 10.
Can you provide the financial health for REAX stock?
The financial health rating of REAL BROKERAGE INC/THE (REAX) is 7 / 10.
Can you provide the expected EPS growth for REAX stock?
The Earnings per Share (EPS) of REAL BROKERAGE INC/THE (REAX) is expected to grow by 67.21% in the next year.